Insider · CIK 0001864406
SoYoung Kwon
Files at APVO (Aptevo Therapeutics Inc.). First filing -, latest -.
In brief
SoYoung Kwon files SEC Form 4 as officer at APVO (Aptevo Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; SoYoung Kwon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +638 | - | - | 638 | Aug 10, 2026 |
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -638 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | AGrant or award Restricted Stock Unitderivative | +11,500 | $0.00 | $0 | 11,500 | Aug 8, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +3 | - | - | 4 | Jul 21, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -3 | $0.00 | $0 | 8 | Jul 21, 2025 |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +2 | - | - | 23 | Mar 4, 2025 |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +2 | - | - | 25 | Mar 4, 2025 |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -2 | $0.00 | $0 | 2 | Mar 4, 2025 |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -2 | $0.00 | $0 | 0 | Mar 4, 2025 |
| May 31, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +42 | - | - | 588 | Jun 3, 2024 |
| May 31, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -42 | $0.00 | $0 | 0 | Jun 3, 2024 |
| Mar 2, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +3,667 | - | - | 20,375 | Mar 5, 2024 |
| Mar 3, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +3,667 | - | - | 24,042 | Mar 5, 2024 |
| Mar 2, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -3,667 | $0.00 | $0 | 7,333 | Mar 5, 2024 |
| Mar 3, 2024 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -3,667 | $0.00 | $0 | 3,667 | Mar 5, 2024 |
Questions about SoYoung Kwon
Answered from the filings on this page, as of the latest one.
Is SoYoung Kwon buying or selling?
SoYoung Kwon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did SoYoung Kwon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and SoYoung Kwon has 0.
Where does SoYoung Kwon file Form 4?
SoYoung Kwon has filed Form 4 at APVO (Aptevo Therapeutics Inc.) as SVP, GC, BD & Corp Affairs. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.